Cordyceps, Scarlet Club · 2025 · Research Support, Non U.S. Gov'T
Medium relevanceSynergistic Effect of HAD-B1 and Osimertinib Against Gefitinib Resistant HCC827 Non-Small Cell Lung Cancer Cells.
Cordyceps militaris
OncologyEnergy & fatigueRespiratory
Metadata-grounded summary
Article summary
Metadata-grounded summary: This research support, non u.s. gov't indexes research on Cordyceps militaris in Integrative cancer therapies in 2025. MycoData maps the paper to oncology, energy & fatigue, respiratory based on its title, species context, article metadata, and study classification.
Citation
Ko EJ, Kwag EB, Park JH, Cho SH, Park SJ, Jung MK, et al. (2025). Synergistic Effect of HAD-B1 and Osimertinib Against Gefitinib Resistant HCC827 Non-Small Cell Lung Cancer Cells. Integrative cancer therapies https://doi.org/10.1177/15347354241307006 PMID: 39819155
Open citation